Clinical trial
A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions - The BIFSORB Pilot Study II
NCT03027856 is registered in ClinicalTrials.gov with Aarhus University Hospital Skejby as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions - The BIFSORB Pilot Study II
- Lead sponsor
- Aarhus University Hospital Skejby
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2016
- Completion date
- December 31, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.